Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 3:09 pm Purchase |
2021-12-31 | 13G | Magenta Therapeutics, Inc. MGTA |
Aquilo Capital Management LLC | 3,155,082 5.400% |
3,155,082 (New Position) |
Filing History |
| 2022-02-14 08:58 am Purchase |
2021-12-31 | 13G | Magenta Therapeutics, Inc. MGTA |
Deep Track Capital, LP | 4,870,000 8.290% |
714,445 (+17.19%) |
Filing History |
| 2022-02-14 07:04 am Sale |
2021-12-31 | 13G | Magenta Therapeutics, Inc. MGTA |
GILDER GAGNON HOWE & CO LLC | 3,675,608 6.300% |
-542,598 (-12.86%) |
Filing History |
| 2022-02-11 10:00 pm Purchase |
2021-12-31 | 13G | Magenta Therapeutics, Inc. MGTA |
Casdin Capital, LLC | 3,901,589 6.640% |
555,554 (+16.60%) |
Filing History |
| 2021-05-14 4:05 pm Purchase |
2021-05-14 | 13G | Magenta Therapeutics, Inc. MGTA |
Deep Track Capital, LP | 4,155,555 7.140% |
4,155,555 (New Position) |
Filing History |
| 2021-02-17 08:26 am Sale |
2021-02-11 | 13D | Magenta Therapeutics, Inc. MGTA |
Atlas Venture Fund X L.P. | 3,357,340 7.000% |
-759,785 (-18.45%) |
Filing History |
| 2021-02-16 10:04 am Purchase |
2020-12-31 | 13G | Magenta Therapeutics, Inc. MGTA |
GILDER GAGNON HOWE & CO LLC | 4,218,206 8.730% |
114,781 (+2.80%) |
Filing History |
| 2021-02-12 4:15 pm Sale |
2020-12-31 | 13G | Magenta Therapeutics, Inc. MGTA |
Eventide Asset Management, LLC | 1,000,000 2.100% |
-2,393,894 (-70.54%) |
Filing History |
| 2021-02-11 10:25 am Purchase |
2020-12-31 | 13G | Magenta Therapeutics, Inc. MGTA |
Casdin Capital, LLC | 3,346,035 6.930% |
247,913 (+8.00%) |
Filing History |
| 2020-07-14 4:34 pm Unchanged |
2020-06-29 | 13D | Magenta Therapeutics, Inc. MGTA |
Atlas Venture Fund X L.P. | 4,117,125 8.700% |
0 (Unchanged) |
Filing History |